Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$8.48 - $11.13 $3.47 Million - $4.56 Million
-409,706 Reduced 85.24%
70,922 $604,000
Q2 2022

Aug 10, 2022

BUY
$9.95 - $12.27 $287,296 - $354,283
28,874 Added 6.39%
480,628 $5.03 Million
Q1 2022

May 10, 2022

SELL
$9.81 - $15.4 $342,673 - $537,937
-34,931 Reduced 7.18%
451,754 $4.92 Million
Q4 2021

Feb 04, 2022

SELL
$12.09 - $14.68 $1.22 Million - $1.48 Million
-100,941 Reduced 17.18%
486,685 $6.59 Million
Q3 2021

Nov 05, 2021

SELL
$13.25 - $15.13 $96,937 - $110,691
-7,316 Reduced 1.23%
587,626 $7.96 Million
Q2 2021

Aug 12, 2021

BUY
$12.97 - $16.15 $167,053 - $208,011
12,880 Added 2.21%
594,942 $8.5 Million
Q1 2021

May 10, 2021

SELL
$13.59 - $18.54 $66.6 Million - $90.8 Million
-4,899,078 Reduced 89.38%
582,062 $8.13 Million
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $75.1 Million - $98.5 Million
5,255,167 Added 2325.57%
5,481,140 $103 Million
Q4 2020

Feb 04, 2021

BUY
$14.3 - $18.74 $3.23 Million - $4.23 Million
225,973 New
225,973 $4.23 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $11.7B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.